GENEVA, July 31 -- REMEGEN CO., LTD. filed a patent application (CN2026/074177) for “METHOD FOR TREATING NON-SMALL CELL LUNG CANCER USING ANTI-PD-1 AND VEGF BISPECIFIC ANTIBODY”. With publication no. WO/2026/158443, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 39/395
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....